Brain Health: Fighting Memory Loss
Mark Underwood, president and founder of Quincy Bioscience joins the program to discuss brain health and memory loss; how big of a problem is this in the U.S., what does science say about the connection of differing types of memory loss? Mark will answer these questions and more.
Mark Underwood is President and a Founder of Quincy Bioscience, LLC, a biotechnology company focusing on the diseases of aging. Quincy has identified the fundamental factor in the aging process and age-related diseases such as Alzheimer’s and Parkinson’s. Quincy has also developed a therapeutic compound for the treatment of these neurodegenerative diseases that is currently in the pre-clinical stage of development. The focus of Quincy Bioscience’s development work revolves around calcium regulation related to aging and age-related disorders and their technology derived from an active compound naturally found in jellyfish.
Quincy has developed products for the dietary supplement marketplace under the brand Prevagen® and also is pursuing pharmaceutical applications of their technology. Quincy is growing rapidly and had their first national product launch September 1, 2007 of Prevagen. Quincy Bioscience’s headquarters are located in Madison, Wisconsin within the University of Wisconsin’s University Research Park.
In addition to product development, Mark is also an author. He released his first book in the fall of 2007 entitled Gift from the Sea – How a protein from jellyfish fights the aging process. Mark’s own family struggle with the diseases of the brain was one of the inspirations that motivated him to create Prevagen and is described in this book. He explains why brain cells die and the research that proves Prevagen can help.
Dr. Derrick DeSilva